HOME >> MEDICINE >> NEWS
Scripps research combination therapy obliterates new vessel growth in tumors and retinopathy

e use of lower doses of angiostatic therapies could minimize potential adverse side effects.

"The point of the study was to show proof-of-concept that targeting multiple angiogenic pathways will be more effective than inhibiting single ones due to potential compensatory upregulation," Friedlander said. "As more and more anti-angiogenic agents reach the market, there will be even more combinations to choose from. In our laboratory, we're now looking at new combinations of approved angiostatic drugs to see if we can achieve similar promising results that can have immediate translation into the clinic."


'"/>

Contact: Marisela Chevez
mchevez@scripps.edu
858-784-2171
Scripps Research Institute
9-Jan-2007


Page: 1 2 3

Related medicine news :

1. Scripps Research awarded $17 million for adult stem cell use to treat eye diseases
2. Synthetic production of potential pharmaceuticals dramatically simplified by Scripps research team
3. The Scripps Research Institute, McDonalds align to fight childhood obesity and type 2 diabetes
4. Scripps research team reverses Friedreichs ataxia defect in cell culture
5. Scripps research scientists test anti-obesity vaccine
6. 1 of 2 pediatric kidney disease research centers in world established
7. Stanford researchers find culprit in aging muscles that heal poorly
8. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
9. Indiana University Imaging Center receives $6M grant for kidney research
10. Penn researchers discover novel pathway for increasing good cholesterol
11. New research discovers independent brain networks control human walking

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/20/2017)... ... , ... Clearwave is the leading provider in ... XT-series of touch screen terminals. Both companies will be showcasing their solutions at ... provider Posiflex is helping to bridge the gap between healthcare hardware and software ...
(Date:2/20/2017)... ... 20, 2017 , ... Best Doctors® and IBM today announced ... companies that want to help members of their workforce battling cancer. Through the ... Watson’s suite of oncology offerings for insights on cancer treatment options, ranging from ...
(Date:2/20/2017)... TX (PRWEB) , ... February 20, 2017 , ... Chuck ... of Sensory Sensitive Sundays, a joint event at Chuck E. Cheese’s locations throughout New ... and other special needs, the opportunity to experience the fun of visiting Chuck E. ...
(Date:2/19/2017)... ... 19, 2017 , ... Braun Industries will be participating as an exhibitor at ... take place February 23-25, 2017 at the Calvin L. Rampton Salt Palace Convention Center ... new ambulances on display. , “JEMS is a leader in EMS ...
(Date:2/18/2017)... ... February 17, 2017 , ... ... Sponsored by Axendia, **FDAnews Free Webinar**, March 1, 2017 — 1:30 p.m. ... reduce their regulatory burden? Pay dividends in enhanced and predictable product performance? ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... Feb. 20, 2017 Research and Markets has ... Insights, Opportunity, Analysis, Market Shares & Forecast 2017 - 2022" ... ... nearly USD 2 Billion by the year end of 2022 growing ... Market growth can be attributed to factors such as ...
(Date:2/20/2017)... , Feb. 20, 2017   AT&T ... physicians diagnose and treat patients with cardiovascular disease ... wireless connectivity for ZywiePro, Zywie,s cardiac remote monitoring ... Control Center . AT&T and Zywie ... for those with the disease. The Internet of ...
(Date:2/20/2017)... 2017 Seal Shield LLC ( Jacksonville, ... mobile device management and disinfection, the ElectroClave™, to the ... in Orlando, Fla. from February ... have become commonplace in today,s healthcare landscape, but with ... concerns, including the disinfection and tracking of these devices.  ...
Breaking Medicine Technology:
Cached News: